{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:48:23Z","timestamp":1789501703039,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.gtc.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T03:43:15Z","timestamp":1544672595000},"page":"145-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Nondietary Therapies for Celiac Disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Gloria","family":"Serena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.gtc.2018.09.011_bib1","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMcp1113994","article-title":"Clinical practice. Celiac disease","volume":"367","author":"Fasano","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/17474124.2014.887438","article-title":"Refractory celiac disease","volume":"8","author":"Malamut","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.gtc.2018.09.011_bib3","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ajg.2014.29","article-title":"Patient perception of treatment burden is high in celiac disease compared with other common conditions","volume":"109","author":"Shah","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"95","key":"10.1016\/j.gtc.2018.09.011_bib4","first-page":"285","article-title":"Novel therapeutic approaches for celiac disease","volume":"17","author":"Vanga","year":"2014","journal-title":"Discov Med"},{"issue":"2","key":"10.1016\/j.gtc.2018.09.011_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/17474124.2014.945915","article-title":"Genetics and celiac disease: the importance of screening","volume":"9","author":"Leonard","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol Rev"},{"issue":"19","key":"10.1016\/j.gtc.2018.09.011_bib7","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1016\/j.yexcr.2009.06.026","article-title":"Toxic peptides in Frazer's fraction interact with the actin cytoskeleton and affect the targeting and function of intestinal proteins","volume":"315","author":"Reinke","year":"2009","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2008.03.023","article-title":"Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3","volume":"135","author":"Lammers","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clim.2010.01.003","article-title":"Monocytes differentiated with IL-15 support Th17 and Th1 responses to wheat gliadin: implications for celiac disease","volume":"135","author":"Harris","year":"2010","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","article-title":"Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease","volume":"125","author":"Mention","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bpg.2015.05.001","article-title":"Innate immunity: actuating the gears of celiac disease pathogenesis","volume":"29","author":"Kim","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2018.09.011_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cgh.2006.11.014","article-title":"Neutrophil recruitment and barrier impairment in celiac disease: a genomic study","volume":"5","author":"Diosdado","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2567.2010.03378.x","article-title":"Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease","volume":"132","author":"Lammers","year":"2011","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.gtc.2018.09.011_bib14","doi-asserted-by":"crossref","first-page":"e0138338","DOI":"10.1371\/journal.pone.0138338","article-title":"Gliadin induces neutrophil migration via engagement of the formyl peptide receptor, FPR1","volume":"10","author":"Lammers","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/open.201700197","article-title":"Translational chemistry meets gluten-related disorders","volume":"7","author":"Lammers","year":"2018","journal-title":"ChemistryOpen"},{"issue":"5","key":"10.1016\/j.gtc.2018.09.011_bib16","doi-asserted-by":"crossref","first-page":"e0126291","DOI":"10.1371\/journal.pone.0126291","article-title":"TNF-alpha producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice","volume":"10","author":"Marafini","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.gtc.2018.09.011_bib17","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.1601693","article-title":"T\u00a0cells in celiac disease","volume":"198","author":"Jabri","year":"2017","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.gtc.2018.09.011_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MOG.0b013e3283365263","article-title":"Celiac disease","volume":"26","author":"Rubio-Tapia","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000260087","article-title":"Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease","volume":"152","author":"Sapone","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"issue":"7","key":"10.1016\/j.gtc.2018.09.011_bib20","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10620-008-0501-x","article-title":"Regulatory T-cell function is impaired in celiac disease","volume":"54","author":"Granzotto","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/cei.12911","article-title":"Proinflammatory cytokine interferon-gamma and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease","volume":"187","author":"Serena","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.gtc.2018.09.011_bib22","doi-asserted-by":"crossref","first-page":"e0144634","DOI":"10.1371\/journal.pone.0144634","article-title":"Celiac disease histopathology recapitulates Hedgehog downregulation, consistent with wound healing processes activation","volume":"10","author":"Senger","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gtc.2018.09.011_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpeds.2016.08.049","article-title":"Transitioning from descriptive to mechanistic understanding of the microbiome: the need for a prospective longitudinal approach to predicting disease","volume":"179","author":"Martin","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.gtc.2018.09.011_bib24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/MIB.0b013e31828029a9","article-title":"The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease","volume":"19","author":"Wacklin","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2018.09.011_bib25","article-title":"Faecal short-chain fatty acid pattern in childhood coeliac disease is normalised after more than one year's gluten-free diet","volume":"24","author":"Tjellstrom","year":"2013","journal-title":"Microb Ecol Health Dis"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.011_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ibd.21830","article-title":"Differences of small intestinal bacteria populations in adults and children with\/without celiac disease: effect of age, gluten diet, and disease","volume":"18","author":"Nistal","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jcp.2008.061366","article-title":"Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease","volume":"62","author":"Collado","year":"2009","journal-title":"J\u00a0Clin Pathol"},{"issue":"12","key":"10.1016\/j.gtc.2018.09.011_bib28","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1038\/ajg.2009.524","article-title":"Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease","volume":"104","author":"Ou","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"Pt 12","key":"10.1016\/j.gtc.2018.09.011_bib29","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1099\/jmm.0.47410-0","article-title":"Imbalance in the composition of the duodenal microbiota of children with coeliac disease","volume":"56","author":"Nadal","year":"2007","journal-title":"J\u00a0Med Microbiol"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ismej.2016.114","article-title":"Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis","volume":"11","author":"Meisel","year":"2017","journal-title":"ISME J"},{"issue":"6","key":"10.1016\/j.gtc.2018.09.011_bib31","doi-asserted-by":"crossref","first-page":"e0128065","DOI":"10.1371\/journal.pone.0128065","article-title":"Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements","volume":"10","author":"Janssen","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.gtc.2018.09.011_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1756283X17690991","article-title":"Commercially available glutenases: a potential hazard in coeliac disease","volume":"10","author":"Krishnareddy","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2018.09.011_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10620-011-1906-5","article-title":"Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials","volume":"57","author":"Siegel","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clim.2009.11.001","article-title":"The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in\u00a0vivo","volume":"134","author":"Tye-Din","year":"2010","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1016\/j.gtc.2018.09.011_bib35","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"Lahdeaho","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.011_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No difference between latiglutenase and placebo in reducing villus atrophy or improving symptoms in patients with symptomatic celiac disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2018.09.011_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00261-016-1032-0","article-title":"Cross-sectional imaging in refractory celiac disease","volume":"42","author":"Al-Bawardy","year":"2017","journal-title":"Abdom Radiol (NY)"},{"issue":"7","key":"10.1016\/j.gtc.2018.09.011_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1542-3565(05)00366-6","article-title":"Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue","volume":"3","author":"Pyle","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.011_bib39","doi-asserted-by":"crossref","first-page":"G621","DOI":"10.1152\/ajpgi.00034.2006","article-title":"Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease","volume":"291","author":"Stepniak","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gut.2006.111609","article-title":"Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease","volume":"57","author":"Mitea","year":"2008","journal-title":"Gut"},{"issue":"50","key":"10.1016\/j.gtc.2018.09.011_bib41","doi-asserted-by":"crossref","first-page":"20513","DOI":"10.1021\/ja3094795","article-title":"Computational design of an alpha-gliadin peptidase","volume":"134","author":"Gordon","year":"2012","journal-title":"J\u00a0Am Chem Soc"},{"issue":"40","key":"10.1016\/j.gtc.2018.09.011_bib42","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/jacs.5b08325","article-title":"Engineering of Kuma030: a gliadin peptidase that rapidly degrades immunogenic gliadin peptides in gastric conditions","volume":"137","author":"Wolf","year":"2015","journal-title":"J\u00a0Am Chem Soc"},{"issue":"2","key":"10.1016\/j.gtc.2018.09.011_bib43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2011.10.038","article-title":"The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues","volume":"142","author":"Pinier","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2018.09.011_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/gut.44.2.212","article-title":"Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine","volume":"44","author":"Warny","year":"1999","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.gtc.2018.09.011_bib45","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1021\/jf205319s","article-title":"In-vitro and in-vivo binding activity of chicken egg yolk immunoglobulin Y (IgY) against gliadin in food matrix","volume":"60","author":"Gujral","year":"2012","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.gtc.2018.09.011_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12865-015-0104-1","article-title":"Effect of anti-gliadin IgY antibody on epithelial intestinal integrity and inflammatory response induced by gliadin","volume":"16","author":"Gujral","year":"2015","journal-title":"BMC Immunol"},{"issue":"2","key":"10.1016\/j.gtc.2018.09.011_bib47","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AEM.70.2.1088-1096.2004","article-title":"Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients","volume":"70","author":"Di Cagno","year":"2004","journal-title":"Appl Environ Microbiol"},{"issue":"14","key":"10.1016\/j.gtc.2018.09.011_bib48","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1128\/AEM.00260-07","article-title":"Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease","volume":"73","author":"Rizzello","year":"2007","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"10.1016\/j.gtc.2018.09.011_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MPG.0b013e3181f22ba4","article-title":"Gluten-free sourdough wheat baked goods appear safe for young celiac patients: a pilot study","volume":"51","author":"Di Cagno","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cgh.2010.09.025","article-title":"Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing","volume":"9","author":"Greco","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbadis.2005.09.008","article-title":"VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue","volume":"1762","author":"De Angelis","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/gast.2001.27224","article-title":"Probiotic bacteria enhance murine and human intestinal epithelial barrier function","volume":"121","author":"Madsen","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib53","doi-asserted-by":"crossref","first-page":"e17366","DOI":"10.1371\/journal.pone.0017366","article-title":"Effect of hookworm infection on wheat challenge in celiac disease\u2013a randomised double-blinded placebo controlled trial","volume":"6","author":"Daveson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gtc.2018.09.011_bib54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2000.tb05244.x","article-title":"Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin","volume":"915","author":"Fasano","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.011_bib55","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/00365520500235334","article-title":"Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines","volume":"41","author":"Drago","year":"2006","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.011_bib56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s10620-009-0813-5","article-title":"A\u00a0comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet","volume":"55","author":"Duerksen","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.peptides.2012.02.015","article-title":"Larazotide acetate regulates epithelial tight junctions in\u00a0vitro and in\u00a0vivo","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.peptides.2012.02.016","article-title":"Larazotide acetate promotes tight junction assembly in epithelial cells","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.gtc.2018.09.011_bib59","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2007.03413.x","article-title":"The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study","volume":"26","author":"Paterson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.gtc.2018.09.011_bib60","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/ajg.2012.211","article-title":"A\u00a0randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge","volume":"107","author":"Leffler","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2018.09.011_bib61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.12147","article-title":"Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study","volume":"37","author":"Kelly","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.gtc.2018.09.011_bib62","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib63","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10875-012-9745-5","article-title":"Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study","volume":"33","author":"Rauhavirta","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"13","key":"10.1016\/j.gtc.2018.09.011_bib64","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1073\/pnas.0832466100","article-title":"Transglutaminase 2-\/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells","volume":"100","author":"Szondy","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"5","key":"10.1016\/j.gtc.2018.09.011_bib65","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.molimm.2009.10.036","article-title":"Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule","volume":"47","author":"Kapoerchan","year":"2010","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.011_bib66","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4049\/jimmunol.114.4.1296","article-title":"The role of macrophages in the production of lymphokines by T and B lymphocytes","volume":"114","author":"Wahl","year":"1975","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.011_bib67","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cbpb.2009.04.007","article-title":"Functional differential immune responses of Mytilus galloprovincialis to bacterial challenge","volume":"153","author":"Ciacci","year":"2009","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"9","key":"10.1016\/j.gtc.2018.09.011_bib68","first-page":"582","article-title":"Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet","volume":"8","author":"Bakshi","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"7","key":"10.1016\/j.gtc.2018.09.011_bib69","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cgh.2010.04.009","article-title":"Celiac crisis is a rare but serious complication of celiac disease in adults","volume":"8","author":"Jamma","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2018.09.011_bib70","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1053\/j.gastro.2009.09.008","article-title":"Celiac disease: from pathogenesis to novel therapies","volume":"137","author":"Schuppan","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2018.09.011_bib71","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/gut.36.6.874","article-title":"Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody","volume":"36","author":"Przemioslo","year":"1995","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2018.09.011_bib72","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/jpet.108.148007","article-title":"Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T\u00a0cells enhances the transepithelial flux of gluten peptides","volume":"329","author":"Bethune","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.011_bib73","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1053\/gast.2002.31874","article-title":"Successful infliximab treatment for steroid-refractory celiac disease: a case report","volume":"122","author":"Gillett","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.dld.2006.10.017","article-title":"Treatment of life-threatening type I refractory coeliac disease with long-term infliximab","volume":"40","author":"Costantino","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.011_bib75","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/gast.2000.18149","article-title":"Interleukin 15 mediates epithelial changes in celiac disease","volume":"119","author":"Maiuri","year":"2000","journal-title":"Gastroenterology"},{"issue":"37","key":"10.1016\/j.gtc.2018.09.011_bib76","doi-asserted-by":"crossref","first-page":"15849","DOI":"10.1073\/pnas.0908834106","article-title":"Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes","volume":"106","author":"Yokoyama","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib77","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/gut.2003.023150","article-title":"Recombinant human interleukin 10 suppresses gliadin dependent T\u00a0cell activation in ex\u00a0vivo cultured coeliac intestinal mucosa","volume":"54","author":"Salvati","year":"2005","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.gtc.2018.09.011_bib78","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1016\/S0002-9270(01)03897-7","article-title":"The tissue transglutaminase gene is not a primary factor predisposing to celiac disease","volume":"96","author":"van Belzen","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2018.09.011_bib79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa020732","article-title":"Natalizumab for active Crohn's disease","volume":"348","author":"Ghosh","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.gtc.2018.09.011_bib80","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.humpath.2008.10.014","article-title":"Increased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin alpha4beta7-positive T\u00a0cells in blood","volume":"40","author":"Di Sabatino","year":"2009","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.gtc.2018.09.011_bib81","first-page":"472","article-title":"GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease","volume":"13","author":"Eksteen","year":"2010","journal-title":"IDrugs"},{"issue":"5","key":"10.1016\/j.gtc.2018.09.011_bib82","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.1004175","article-title":"Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells","volume":"187","author":"Getts","year":"2011","journal-title":"J\u00a0Immunol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855318300876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855318300876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:28:41Z","timestamp":1760178521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855318300876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0889855318300876"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2018.09.011","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nondietary Therapies for Celiac Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}